Skip to main content
Top
Published in: BMC Endocrine Disorders 1/2019

Open Access 01-12-2019 | Obesity | Research article

An in-depth analysis of glycosylated haemoglobin level, body mass index and left ventricular diastolic dysfunction in patients with type 2 diabetes

Authors: Xin Zuo, Xueting Liu, Runtian Chen, Huiting Ou, Jiabao Lai, Youming Zhang, Dewen Yan

Published in: BMC Endocrine Disorders | Issue 1/2019

Login to get access

Abstract

Background

Glycosylated hemoglobin (HbA1c) has a detrimental impact on the myocardium with left ventricular (LV) diastolic dysfunction. Obesity is a risk factor of type 2 diabetes. To understand the relationships between HbA1c, body mass index (BMI) and LV diastolic dysfunction, we performed this interaction analysis in patients with type 2 diabetes.

Methods

Total 925 type 2 diabetes patients were selected from the patients who were diagnosed and treated at the First Affiliated Hospital of Shenzhen University. Patients’ BMI levels were defined as normal (BMI < 24 kg/m2) and overweight /obese (BMI ≥ 24 kg/m2). Patients’ HbA1c levels were grouped as HbA1c ≥ 9%、7% ≤ HbA1c < 9% and HbA1c < 7%. Logistic regression, stratified, interaction analysis, multivariate Cox regression and curve fitting analysis were performed to investigate the correlations and interactions between HbA1c and BMI with LV diastolic dysfunction.

Results

The BMI levels were significantly associated with LV diastolic dysfunction in the patients with type 2 diabetes [adjusted model: 1.12 (1.05, 1.20), P = 0.001]. While HbA1c levels had association with LV diastolic dysfunction only in normal BMI group patients [adjusted model: 1.14 (1.01, 1.30), P = 0.0394] and curve correlation was observed. There was a significant interaction between BMI and HbA1c to affect LV diastolic dysfunction (P = 0.0335). Cox regression model analysis showed that the risk of LV diastolic dysfunction was a U type correlation with HbA1c levels in the normal weight group and the turning point was HbA1c at 10%. HbA1c level was not found to have a significant association with LV diastolic dysfunction in overweight/obese group.

Conclusions

In patients with type 2 diabetes, correlation between LV diastolic dysfunction and HbA1c was interactively affected by BMI. Glycemic control is beneficial to the heart function in normal body weight patients. For overweight/obese patients, the risk of LV diastolic dysfunction was not determined by the HbA1c level, indicating it may be affected by other confounding factors.
Literature
1.
go back to reference Zimmet P, Alberti KG, Shaw J. Global and societal implications of the diabetes epidemic. Nature. 2001;414(6865):782–7.CrossRef Zimmet P, Alberti KG, Shaw J. Global and societal implications of the diabetes epidemic. Nature. 2001;414(6865):782–7.CrossRef
2.
go back to reference Zinman B, Wanner C, Lachin JM, Fitchett D, Bluhmki E, Hantel S, et al. Empagliflozin, cardiovascular outcomes, and mortality in type 2 Diabetes. N Engl J Med. 2015;373(22):2117–28.CrossRef Zinman B, Wanner C, Lachin JM, Fitchett D, Bluhmki E, Hantel S, et al. Empagliflozin, cardiovascular outcomes, and mortality in type 2 Diabetes. N Engl J Med. 2015;373(22):2117–28.CrossRef
3.
go back to reference Galderisi M. Diastolic dysfunction and diabetic cardiomyopathy: evaluation by Doppler echocardiography. J Am Coll Cardiol. 2006;48(8):1548–51.CrossRef Galderisi M. Diastolic dysfunction and diabetic cardiomyopathy: evaluation by Doppler echocardiography. J Am Coll Cardiol. 2006;48(8):1548–51.CrossRef
4.
go back to reference Schannwell CM, Schneppenheim M, Perings S, Plehn G, Strauer BE. Left ventricular diastolic dysfunction as an early manifestation of diabetic cardiomyopathy. Cardiology. 2002;98(1–2):33–9.CrossRef Schannwell CM, Schneppenheim M, Perings S, Plehn G, Strauer BE. Left ventricular diastolic dysfunction as an early manifestation of diabetic cardiomyopathy. Cardiology. 2002;98(1–2):33–9.CrossRef
5.
go back to reference Boudina S, Abel ED. Diabetic cardiomyopathy revisited. Circulation. 2007;115(25):3213–23.CrossRef Boudina S, Abel ED. Diabetic cardiomyopathy revisited. Circulation. 2007;115(25):3213–23.CrossRef
6.
go back to reference Zhou YT, Grayburn P, Karim A, Shimabukuro M, Higa M, Baetens D, et al. Lipotoxic heart disease in obese rats: implications for human obesity. Proc Natl Acad Sci U S A. 2000;97(4):1784–9.CrossRef Zhou YT, Grayburn P, Karim A, Shimabukuro M, Higa M, Baetens D, et al. Lipotoxic heart disease in obese rats: implications for human obesity. Proc Natl Acad Sci U S A. 2000;97(4):1784–9.CrossRef
7.
go back to reference Yan D, Luo X, Li Y, Liu W, Deng J, Zheng N, et al. Effects of advanced glycation end products on calcium handling in cardiomyocytes. Cardiology. 2014;129(2):75–83.CrossRef Yan D, Luo X, Li Y, Liu W, Deng J, Zheng N, et al. Effects of advanced glycation end products on calcium handling in cardiomyocytes. Cardiology. 2014;129(2):75–83.CrossRef
8.
go back to reference Parry HM, Deshmukh H, Levin D, Van Zuydam N, Elder DH, Morris AD, et al. Both high and low HbA1c predict incident heart failure in type 2 diabetes mellitus. Circ Heart Fail. 2015;8(2):236–42.CrossRef Parry HM, Deshmukh H, Levin D, Van Zuydam N, Elder DH, Morris AD, et al. Both high and low HbA1c predict incident heart failure in type 2 diabetes mellitus. Circ Heart Fail. 2015;8(2):236–42.CrossRef
9.
go back to reference Stratton IM, Adler AI, Neil HA, Matthews DR, Manley SE, Cull CA, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. Bmj. 2000;321(7258):405–12.CrossRef Stratton IM, Adler AI, Neil HA, Matthews DR, Manley SE, Cull CA, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. Bmj. 2000;321(7258):405–12.CrossRef
10.
go back to reference Patil VC, Patil HV, Shah KB, Vasani JD, Shetty P. Diastolic dysfunction in asymptomatic type 2 diabetes mellitus with normal systolic function. J Cardiovasc Dis Res. 2011;2(4):213–22.CrossRef Patil VC, Patil HV, Shah KB, Vasani JD, Shetty P. Diastolic dysfunction in asymptomatic type 2 diabetes mellitus with normal systolic function. J Cardiovasc Dis Res. 2011;2(4):213–22.CrossRef
11.
go back to reference Yach D, Stuckler D, Brownell KD. Epidemiologic and economic consequences of the global epidemics of obesity and diabetes. Nat Med. 2006;12(1):62–6.CrossRef Yach D, Stuckler D, Brownell KD. Epidemiologic and economic consequences of the global epidemics of obesity and diabetes. Nat Med. 2006;12(1):62–6.CrossRef
12.
go back to reference American Diabetes A. (2) Classification and diagnosis of diabetes. Diabetes Care. 2015;38(Suppl):S8–S16.CrossRef American Diabetes A. (2) Classification and diagnosis of diabetes. Diabetes Care. 2015;38(Suppl):S8–S16.CrossRef
13.
go back to reference Jensen MD, Ryan DH, Apovian CM, Ard JD, Comuzzie AG, Donato KA, et al. 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association task force on practice guidelines and the Obesity Society. Circulation. 2014;129(25 Suppl 2):S102–38.CrossRef Jensen MD, Ryan DH, Apovian CM, Ard JD, Comuzzie AG, Donato KA, et al. 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association task force on practice guidelines and the Obesity Society. Circulation. 2014;129(25 Suppl 2):S102–38.CrossRef
14.
go back to reference Chaudhary AK, Aneja GK, Shukla S, Razi SM. Study on diastolic dysfunction in newly diagnosed type 2 Diabetes mellitus and its correlation with glycosylated Haemoglobin (HbA1C). J Clin Diagn Res : JCDR. 2015;9(8):OC20–2.PubMed Chaudhary AK, Aneja GK, Shukla S, Razi SM. Study on diastolic dysfunction in newly diagnosed type 2 Diabetes mellitus and its correlation with glycosylated Haemoglobin (HbA1C). J Clin Diagn Res : JCDR. 2015;9(8):OC20–2.PubMed
15.
go back to reference Thomas MC. Type 2 Diabetes and heart failure: challenges and solutions. Curr Cardiol Rev. 2016;12(3):249–55.CrossRef Thomas MC. Type 2 Diabetes and heart failure: challenges and solutions. Curr Cardiol Rev. 2016;12(3):249–55.CrossRef
16.
go back to reference Skrtic S, Cabrera C, Olsson M, Schnecke V, Lind M. Contemporary risk estimates of three HbA1c variables in relation to heart failure following diagnosis of type 2 diabetes. Heart. 2017;103(5):353–8.CrossRef Skrtic S, Cabrera C, Olsson M, Schnecke V, Lind M. Contemporary risk estimates of three HbA1c variables in relation to heart failure following diagnosis of type 2 diabetes. Heart. 2017;103(5):353–8.CrossRef
17.
go back to reference Scherer PE, Hill JA. Obesity, Diabetes, and cardiovascular diseases: a compendium. Circ Res. 2016;118(11):1703–5.CrossRef Scherer PE, Hill JA. Obesity, Diabetes, and cardiovascular diseases: a compendium. Circ Res. 2016;118(11):1703–5.CrossRef
18.
go back to reference Seo JS, Jin HY, Jang JS, Yang TH, Kim DK, Kim DS. The relationships between body mass index and left ventricular diastolic function in a structurally Normal heart with Normal ejection fraction. J Cardiovasc Ultrasound. 2017;25(1):5–11.CrossRef Seo JS, Jin HY, Jang JS, Yang TH, Kim DK, Kim DS. The relationships between body mass index and left ventricular diastolic function in a structurally Normal heart with Normal ejection fraction. J Cardiovasc Ultrasound. 2017;25(1):5–11.CrossRef
19.
go back to reference Ng ACT, Prevedello F, Dolci G, Roos CJ, Djaberi R, Bertini M, et al. Impact of Diabetes and increasing body mass index category on left ventricular systolic and diastolic function. J Am Soc Echocardiogr : official publication of the American Society of Echocardiography. 2018;31(8):916–25.CrossRef Ng ACT, Prevedello F, Dolci G, Roos CJ, Djaberi R, Bertini M, et al. Impact of Diabetes and increasing body mass index category on left ventricular systolic and diastolic function. J Am Soc Echocardiogr : official publication of the American Society of Echocardiography. 2018;31(8):916–25.CrossRef
20.
go back to reference Aljaroudi W, Halley C, Houghtaling P, Agarwal S, Menon V, Rodriguez L, et al. Impact of body mass index on diastolic function in patients with normal left ventricular ejection fraction. Nutr Diabetes. 2012;2:e39.CrossRef Aljaroudi W, Halley C, Houghtaling P, Agarwal S, Menon V, Rodriguez L, et al. Impact of body mass index on diastolic function in patients with normal left ventricular ejection fraction. Nutr Diabetes. 2012;2:e39.CrossRef
21.
22.
go back to reference Cohn JN, Johnson G, Ziesche S, Cobb F, Francis G, Tristani F, et al. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med. 1991;325(5):303–10.CrossRef Cohn JN, Johnson G, Ziesche S, Cobb F, Francis G, Tristani F, et al. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med. 1991;325(5):303–10.CrossRef
23.
go back to reference Miki T, Yuda S, Kouzu H, Miura T. Diabetic cardiomyopathy: pathophysiology and clinical features. Heart Fail Rev. 2013;18(2):149–66.CrossRef Miki T, Yuda S, Kouzu H, Miura T. Diabetic cardiomyopathy: pathophysiology and clinical features. Heart Fail Rev. 2013;18(2):149–66.CrossRef
24.
go back to reference American Diabetes A. 6. Glycemic targets: standards of medical Care in Diabetes-2018. Diabetes Care. 2018;41(Suppl 1):S55–64.CrossRef American Diabetes A. 6. Glycemic targets: standards of medical Care in Diabetes-2018. Diabetes Care. 2018;41(Suppl 1):S55–64.CrossRef
25.
go back to reference Skyler JS. Diabetic complications. The importance of glucose control. Endocrinol Metab Clin N Am. 1996;25(2):243–54.CrossRef Skyler JS. Diabetic complications. The importance of glucose control. Endocrinol Metab Clin N Am. 1996;25(2):243–54.CrossRef
26.
go back to reference Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med. 2008;359(15):1577–89.CrossRef Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med. 2008;359(15):1577–89.CrossRef
27.
go back to reference Diabetes C, Complications Trial Research G, Nathan DM, Genuth S, Lachin J, Cleary P, et al. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329(14):977–86.CrossRef Diabetes C, Complications Trial Research G, Nathan DM, Genuth S, Lachin J, Cleary P, et al. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329(14):977–86.CrossRef
28.
go back to reference Giorda CB, Cioffi G, de Simone G, Di Lenarda A, Faggiano P, Latini R, et al. Predictors of early-stage left ventricular dysfunction in type 2 diabetes: results of DYDA study. Eur J Cardiovasc Prev Rehab : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology. 2011;18(3):415–23.CrossRef Giorda CB, Cioffi G, de Simone G, Di Lenarda A, Faggiano P, Latini R, et al. Predictors of early-stage left ventricular dysfunction in type 2 diabetes: results of DYDA study. Eur J Cardiovasc Prev Rehab : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology. 2011;18(3):415–23.CrossRef
29.
go back to reference Clarke GD, Molina-Wilkins M, Solis-Herrera C, Mendez V, Monroy A, Cersosimo E, et al. Impaired left ventricular diastolic function in T2DM patients is closely related to glycemic control. Endocrinol Diabetes Metab. 2018;1(2):e00014.CrossRef Clarke GD, Molina-Wilkins M, Solis-Herrera C, Mendez V, Monroy A, Cersosimo E, et al. Impaired left ventricular diastolic function in T2DM patients is closely related to glycemic control. Endocrinol Diabetes Metab. 2018;1(2):e00014.CrossRef
30.
go back to reference Noh JH, Doh JH, Lee SY, Kim TN, Lee H, Song HY, et al. Risk factors associated with left ventricular diastolic dysfunction in type 2 diabetic patients without hypertension. Korean Diabetes J. 2010;34(1):40–6.CrossRef Noh JH, Doh JH, Lee SY, Kim TN, Lee H, Song HY, et al. Risk factors associated with left ventricular diastolic dysfunction in type 2 diabetic patients without hypertension. Korean Diabetes J. 2010;34(1):40–6.CrossRef
31.
go back to reference Sheth J, Shah A, Sheth F, Trivedi S, Nabar N, Shah N, et al. The association of dyslipidemia and obesity with glycated hemoglobin. Clin Diabetes Endocrinol. 2015;1:6.CrossRef Sheth J, Shah A, Sheth F, Trivedi S, Nabar N, Shah N, et al. The association of dyslipidemia and obesity with glycated hemoglobin. Clin Diabetes Endocrinol. 2015;1:6.CrossRef
32.
go back to reference Gummesson A, Nyman E, Knutsson M, Karpefors M. Effect of weight reduction on glycated haemoglobin in weight loss trials in patients with type 2 diabetes. Diabetes Obes Metab. 2017;19(9):1295–305.CrossRef Gummesson A, Nyman E, Knutsson M, Karpefors M. Effect of weight reduction on glycated haemoglobin in weight loss trials in patients with type 2 diabetes. Diabetes Obes Metab. 2017;19(9):1295–305.CrossRef
33.
go back to reference Carnethon MR, De Chavez PJ, Biggs ML, Lewis CE, Pankow JS, Bertoni AG, et al. Association of weight status with mortality in adults with incident diabetes. Jama. 2012;308(6):581–90.CrossRef Carnethon MR, De Chavez PJ, Biggs ML, Lewis CE, Pankow JS, Bertoni AG, et al. Association of weight status with mortality in adults with incident diabetes. Jama. 2012;308(6):581–90.CrossRef
34.
go back to reference Badrick E, Sperrin M, Buchan IE, Renehan AG. Obesity paradox and mortality in adults with and without incident type 2 diabetes: a matched population-level cohort study. BMJ Open Diabetes Res Care. 2017;5(1):e000369.CrossRef Badrick E, Sperrin M, Buchan IE, Renehan AG. Obesity paradox and mortality in adults with and without incident type 2 diabetes: a matched population-level cohort study. BMJ Open Diabetes Res Care. 2017;5(1):e000369.CrossRef
35.
go back to reference Zhao W, Katzmarzyk PT, Horswell R, Wang Y, Li W, Johnson J, et al. Body mass index and the risk of all-cause mortality among patients with type 2 diabetes mellitus. Circulation. 2014;130(24):2143–51.CrossRef Zhao W, Katzmarzyk PT, Horswell R, Wang Y, Li W, Johnson J, et al. Body mass index and the risk of all-cause mortality among patients with type 2 diabetes mellitus. Circulation. 2014;130(24):2143–51.CrossRef
Metadata
Title
An in-depth analysis of glycosylated haemoglobin level, body mass index and left ventricular diastolic dysfunction in patients with type 2 diabetes
Authors
Xin Zuo
Xueting Liu
Runtian Chen
Huiting Ou
Jiabao Lai
Youming Zhang
Dewen Yan
Publication date
01-12-2019
Publisher
BioMed Central
Published in
BMC Endocrine Disorders / Issue 1/2019
Electronic ISSN: 1472-6823
DOI
https://doi.org/10.1186/s12902-019-0419-7

Other articles of this Issue 1/2019

BMC Endocrine Disorders 1/2019 Go to the issue